Drawing for A-MANSIA

USPTO serial 79260184

A-MANSIA

Reviewed by CopyMark Law Group

Reg. 6044583Status 700Registered
Filing date
Status date
Registration date
May 5, 2020
Examiner
STEEL, ALYSSA PALADINO
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with A-MANSIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Liane L. Churney

Liane L. Churney Flynn Thiel, P.C.2026 Rambling RoadKalamazoo, MI 49008-1631UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Biological preparations for use in cell cultures other than for medical or veterinary purposes; cultures of microorganisms other than for medical or veterinary use; bacterial preparations other than for medical or veterinary purposes; milk ferments for the food industry; milk ferments for industrial purposes; chemical, biochemical and biological preparations intended for industry, scientific and scientific research purposes; cultures of microorganisms and bacterial preparations other than for medical or veterinary use; probiotic bacterial preparations and cultures other than for medical or veterinary purposes; bacterial preparations and cultures for the food industry; bacterial preparations and cultures for the cosmetics industry; biological preparations and cultures of micro-organisms other than for medical or veterinary use; biological preparations and cultures of micro-organisms for the food industry; biological preparations and cultures of micro-organisms for the cosmetics industry; proteins for the food industry; proteins for the manufacture of food supplements; proteins for use in manufacturing processes in the food and pharmaceutical industry; chemical additives for the manufacture of cosmetics; chemical additives for use in the manufacture of food; diagnostic preparations other than for medical purposes; diagnostic reagents other than for medical or veterinary purposes, in particular for scientific or scientific research use; microbiological analysis reagents other than for medical or veterinary purposes, in particular for scientific or scientific research use; in vivo diagnostic reagents for scientific purposesACTIVE—
005Medicines for intestinal disorders; pharmaceutical preparations for cancer treatment; pharmaceutical preparations and substances for cancer treatment; pharmaceutical preparations and substances for cancer prevention; biological preparations for the treatment of cancer; pharmaceutical preparations and substances for treating allergies; bacterial preparations for medical use; bacterial preparations for veterinary use; bacterial preparations and cultures for pharmaceutical, medical and veterinary purposes; probiotic preparations for medical use; probiotic bacterial preparations for medical, pharmaceutical or veterinary purposes; probiotic preparations and supplements for medical purposes; dietetic preparations and food supplements in the nature of dietary supplements; cells for medical use; living cells for medical purposes; living cells for veterinary purposes; dietetic food adapted for medical use; mineral waters adapted for medical use; vitamin fortified beverages for medical purposes; dietetic beverages adapted for medical use; dietetic foods adapted for clinical nutrition; dietetic foods adapted for sick people; confectionery, namely, candy for medical purposes; food for diabetics adapted for medical purposes; drinks for diabetics adapted for medical purposes; food supplements consisting of vitamins; food supplements consisting of amino acids for nutritional purposes; dietary supplements composed of trace elements; food supplements for controlling cholesterol; appetite suppressants; appetite suppressants for medical use; food supplements with cosmetic effect; food supplements for animals; dietary supplements for veterinary use; medicated animal foodstuffs; dietetic foodstuffs adapted for veterinary use; food supplements for pets in the nature of powdered drink mixes; dietary supplements for pets in the nature of treats; nutritional supplements; prebiotic supplements; probiotic supplements; reagents and media for medical and veterinary diagnostic purposes; diagnostic agents for pharmaceutical use; diagnostic agents for medical purposes; food for babies and infants; food preparations for infants and babies; dietetic substances adapted for babies and infants for medical purposes; dietetic drinks for infants and babies adapted for medical purposes; food supplements for babies and infants; milk flour being food for babies and infants; formula for babies and infants; mouthwashes for medical purposes; mouthwashes for medical use; medicated antimicrobial mouthwashes; medicated antiseptic mouthwashes; medicated mouthwashes used as gargles for medical purposes; medicated mouth washes; medicinal mouthwashes to prevent cavities; mouth sprays for medical purposes; medicated toothpastes; medicated dentifricesACTIVE—
042Scientific research; consulting and scientific research in the scientific, technological, and diagnostic fields; consulting and scientific research services in the field of cosmetics; consulting and scientific research in the field of food and nutrition; consulting and scientific research in the veterinary field; scientific laboratory services; biological and medical research services; clinical research in the fields of prevention and treatment of metabolic diseases, cancer and intestinal disorders; scientific laboratory services; bacteriological analyses; laboratory analysis in the field of bacteriology; consultancy with respect to bacteriology; consultancy with respect to bacteriology research; technical consulting relating to scientific research services concerning food and dietary supplements; research in the field of medicines; consultancy, research and development in the pharmaceutical field; laboratory analysis in the field of cosmetics; consulting, research and development in the field of cosmeticsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 5, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 3, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 10, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 9, 2020FIMPFINAL DISPOSITION PROCESSED—
Aug 6, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 5, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 7, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 5, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 18, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 18, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 14, 2020GPNXNOTIFICATION PROCESSED BY IB—
Jan 29, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 29, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 29, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 14, 2020ALIEASSIGNED TO LIE—
Jan 10, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 9, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 9, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 9, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 31, 2019ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Aug 2, 2019RFNTREFUSAL PROCESSED BY IB—
Jul 12, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 12, 2019RFRRREFUSAL PROCESSED BY MPU—
Jun 28, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 25, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 24, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 24, 2019DOCKASSIGNED TO EXAMINER—
Jun 24, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 17, 2019LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jun 6, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance